Adult Cancer Patient Recruitment and Enrollment into Cell Phone Text Message Trials

Autor: Barbara A. Given, Sandra L. Spoelstra, Atreyee Majumder, Constantinos K. Coursaris, Monica Schueller, Charles W. Given, Alla Sikorskii
Rok vydání: 2016
Předmět:
Adult
Male
medicine.medical_specialty
Health Status
Reminder Systems
Antineoplastic Agents
Health Informatics
Community Pharmacy Services
Cancer Care Facilities
Severity of Illness Index
Medication Adherence
law.invention
03 medical and health sciences
Social support
0302 clinical medicine
Patient satisfaction
Health Information Management
Randomized controlled trial
law
Neoplasms
Severity of illness
medicine
Humans
030212 general & internal medicine
Aged
Neoplasm Staging
Original Research
Text Messaging
Depression
business.industry
Patient Selection
Social Support
Cancer
General Medicine
Middle Aged
medicine.disease
Self Efficacy
Patient recruitment
Socioeconomic Factors
Patient Satisfaction
030220 oncology & carcinogenesis
Family medicine
Specialty pharmacy
Physical therapy
Female
business
Cell Phone
Zdroj: Telemedicine and e-Health. 22:836-842
ISSN: 1556-3669
1530-5627
Popis: Introduction: Text messaging (TMs) on cell phones is emerging as an effective means of delivering behavioral interventions. However, little is known about TM use in adult cancer patients. The present study aimed to extend knowledge on acceptability of a TM intervention in adult cancer patients; examine factors of those screened and enrolled; and compare recruitment at a large national specialty pharmacy versus community-based cancer clinics. Materials and Methods: Screening, enrollment, and baseline data collected in two randomized controlled trials examining the efficacy of TMs on medication adherence or symptom severity in adults prescribed oral anticancer agents were linked. Chi-square, Fisher's exact, t-tests, and generalized linear modeling were used to examine sociodemographics, cancer type and stage, depressive symptoms, self-efficacy, social support, and symptoms. Results: The cancer clinics screened 293 patients, 43% were eligible, and 56% consented. The specialty pharmacy screened 169 patients, 72% were eligible, and 74% consented. Mean age was 58 years and did not differ by recruitment setting. Later stage disease (p = 0.01) and higher number of symptoms (p < 0.01), and symptom severity (p = 0.02) and interference (p = 0.01) were observed among patients recruited at the specialty pharmacy. No group differences were found for depression, physical function, cognition, self-efficacy, or social support. Discussion: Adult cancer patients were likely to participate in a TM intervention trial. Recruiting through the specialty pharmacy reached a population with higher cell phone ownership and TM usage; with greater interest in a TM intervention compared to the cancer clinics.
Databáze: OpenAIRE